BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
CLSA Maintains Buy on Sun Pharma
CLSA has maintained its buy call on Sun Pharma and raised its target price from Rs 1,130 to Rs 1,160 per share. CLSA says that USFDA resolution at Mohali facility is key and expects growth momentum to pick up in Q1 of FY16.